Your trusted source for investing success

Tag: biomedical

Free 2017 Lithium Investment Report

Your free report includes:

  • Expert commentary
  • Stocks to buy
  • Market forecasts
Give me my free report!  

PyroGenesis Announces Completion of Ramp-Up Phase of 1st Plasma Atomization System

PyroGenesis Canada (TSXV:PYR) has announced it has completed the ramp-up phase of its first plasma atomization system.

As quoted in the press release:
During the ramp-up, the following were also achieved:

Six (6) Non-Disclosure Agreements (“NDA”) signed with distributors and 3D printer manufacturers
Three (3) NDAs being negotiated with multinational aircraft engine

PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia

PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia

PUF Ventures (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder.

 “The goal of our collaboration with Sphaera Pharma is to put the patient first, especially since QBM-001 targets a rare subset of toddlers

Q BioMed Inc Closes $3,050,390 Equity Financing

Q BioMed Inc Closes $3,050,390 Equity Financing

Q BioMed Inc. (OTCQB:QBIO), is pleased to announce the closing of a $3,050,390 equity financing. The financing with a small group of accredited investors provides the necessary capital to meet near term milestones and catalysts in its most advanced product portfolio assets, including the commercialization of Strontium Chloride 89, multiple IND

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
3 Takeaways from Goldman Sachs on Lithium Investing

URL: https://investingnews.com/daily/resource-investing/energy-investing/lithium-investing/goldman-sachs-lithium-investing/